Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

British Company's New Weapon in War on Superbugs


News provided by

Paver Smith

21 Apr, 2013, 23:01 GMT

Share this article

Share toX

Share this article

Share toX

LIVERPOOL, England, April 22, 2013 /PRNewswire/ --

A REVOLUTIONARY disinfectant that combats norovirus and kills hospital superbugs in just a minute has been developed by a British company.

The Noroclear product, which is the first of its type in the world, has gone on sale in the UK in the form of surface wipes, hand wipes and a hand rub.

Strict European standard tests prove that the product - which is free from bleaches and other dangerous chemicals - combats the norovirus germ within a minute of contact.

It kills superbugs including MRSA, C Difficile, e.coli, salmonella, listeria and all influenza viruses in less than a minute.

Norovirus, sometimes known as the winter vomiting bug, is the most common stomach bug in the UK, affecting between 600,000 and one million people of all ages every year.

The Noroclear developers, a Cheshire-based company called Arcis-Altos, have put their product through a rigorous European testing regime called EN testing. This underpins the company's claims for its killing power against superbugs, all human Flu, HIV, swine flu, SARS virus, TB causing bacteria and norovirus.

Not even harmful bleaches kill the norovirus in such a short space of time. Standard hand alcohol-based hand wipes and rubs are also ineffective.

Other products combat bacteria but are ineffective against not just the norovirus but other human viruses and the spores which cause a wide range of other illnesses.

Noroclear has been developed by a British firm in laboratories at the Sci-Tech Daresbury science campus in Cheshire. It is already in use in clinics and hospitals in Germany and Austria.

The company's chairman, Dr Tim Riley, spent a number of years as chief executive of NHS trusts in the North West of England. He was head of NHS public health policy for the Government in the '90s and led the team which developed and set up the National Institute of Clinical Excellence.

He said: "The technology behind the product is revolutionary in its impact because it gives people one product which deals quickly and across the board with superbugs and common globally occurring debilitating infections. We are recommending that people use it as a simple precautionary measure in situations where the risk of infection is raised, such as when entering hospital or when travelling.

"It will also be extremely useful in helping to prevent the spread of infection in families where one or more people has contracted norovirus.

"We know there are other products out there which claim to be effective in killing these bugs but none of them are proven to act so quickly, so effectively and against such a wide range of pathogens. It is this speed of efficacy which is so important in guarding against infection.

"This speed makes the products convenient and effective in real-life settings - a quick wipe or spray and the germs will be killed within 60 seconds. With other products, you would have to keep using and re-using for at least 15 minutes in many cases before they took effect.

"The rise of superbugs in hospitals and in other settings, aligned with the resistance of these bugs to antibiotics, makes it more important than ever that we concentrate on preventative measures and that individuals take personal responsibility for protecting themselves and their loved ones.

"Effective, affordable and easy-to-use disinfectants are especially important for those who are vulnerable - the very young and the old, plus those recovering from operations. But we believe our technology opens the way for people to take very simple but effective precautionary measures to protect themselves in situations such as the annual family holiday."

Notes to editors follow

Arcis-Altos is a biotechnology company based in a Government Enterprise Zone at Sci-Tech Daresbury, Cheshire. Details of the European test protocol which its Noroclear product has been tested against are below.

                   European
                   test        Contact
    Activity       protocol    time       Organisms

                   EN1276      1 minute   Escherichia coli,Staphylococcus
                                          aureus, Pseudomonas aeruginosa,
                                          Salmonella typhimurium,
                                          Enterobacter cloaca, Enterococcus
                                          hirae,Lactobacillus
                                          planetarium,Klebsiella pneumonia,
                                          Enterococcus faecalis, Proteus
                                          mirabilis, Streptococcus pyogenes,
                                          Salmonella choleraesuis, Listeria
                                          monocytogenes

    Bactericidal   EN13727     1 minute   MRSA, Klebsiella pneumonia,
                                          Staphylococcus aureus, Pseudomonas
                                          aeruginosa, Enterococcus hirae,
                                          Acinetobacter baumannii

                   EN13697     1 minute   Pseudomonas aeruginosa,
                                          Staphylococcus aureus, Escherichia
                                          coli, Enterococcus hirae


                   EN1500      30 seconds Escherichia coli

                   EN1650      1 minute   Candida albicans, Aspergillus
                                          niger, Tricophyton mentagrophytes
    Fungicidal

                   EN13624     1 minute   Aspergillus niger, Candida albicans

    Tuberculocidal EN14348     1 minute   Mycobacterium terrae, Mycobacterium
                                          avium

                   EN14476     1 minute   HIV, Human Corona virus, Human
                                          Influenza virus, Herpes simplex
                                          virus,
    Virucidal                             Swine Influenza A virus Norovirus

                   DVV/RKI     1 minute   Vaccinia virus, BVDV (Hepatitis C
                                          surrogate)

    Sporicidal     EN13704     1 minute   Clostridium difficile
                                          spores,Bacillus subtilis spores,
                                          Clostridium sporogenes spores,
                                          Bacillus cereus spores

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.